.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Cipla
Novartis
Argus Health
Medtronic
Cerilliant
US Department of Justice
Merck
AstraZeneca
McKesson

Generated: January 23, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Italy Patent: MI97A2788

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Forest Labs LlcPYLERAbismuth subcitrate potassium; metronidazole; tetracyclineCAPSULE;ORAL050786-001Sep 28, 2006RXYesYes➤ Subscribe➤ SubscribePYLERA CAPSULES, IN COMBINATION WITH OMEPRAZOLE ARE INDICATED FOR THE TREATMENT OF PATIENTS WITH HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE TO ERADICATE H. PYLORI
Forest Labs LlcPYLERAbismuth subcitrate potassium; metronidazole; tetracyclineCAPSULE;ORAL050786-001Sep 28, 2006RXYesYes➤ Subscribe➤ SubscribeTREATMENT OF PATIENTS WITH H. PYLORI INFECTION AND DUODENAL ULCER DISEASE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist